“STAYING SHARP WITH PARKINSONS”
-Overview of healthy brain function
-Cognitive changes in Parkinson’s disease
-Modifiable risk factors to focus on for healthy brain aging and dementia prevention
Dr. Mariel Deutsch and Dr. Alexander Shtilbans
Dr. Mariel Deutsch is cognitive behavioral neurologist, specializing in the diagnosis and care of people with dementia and other causes for cognitive and behavioral symptoms. She has co-authored numerous peer-reviewed articles and abstracts and 2 textbook chapters. She spent years working at academic centers, teaching the next generation of physicians, participating in clinical research, and giving educational talks on various dementia and behavioral neurology-related topics, all while providing exceptional clinical care. She now provides consultations in her private practice Neurology MIND Care PLLC on Long Island in Merrick, NY. Dr. Deutsch believes in a comprehensive and holistic approach to care and she gives her patients and their families all the time they need.
Dr. Alexander Shtilbans is a board certified neurologist whose clinical interest lies in the area of neurodegenerative diseases, particularly Parkinson's disease. He began his career as a molecular biologist in Neuroscience and, after obtaining his PhD, transitioned into clinical Neurology in order to work with patients and gain a better understanding of the clinical course of these diseases.
Dr. Shtilbans received his medical degree from Mount Sinai School of Medicine, where he also completed his residency in Neurology and served as a chief resident. Subsequently, he trained with Dr. Stanley Fahn during his clinical fellowship in Movement Disorders at Columbia University. Dr. Shtilbans has a longstanding interest in translational research and is currently involved in several clinical trials in Parkinson's Disease.
As a physician scientist, Dr. Shtilbans is interested in developing new therapies that will slow down the progression of neurodegenerative diseases. His goal is to better understand molecular mechanisms of the neurodegenerative processes by being actively involved in both clinical and basic science research.
Dr. Shtilbans serves as a co-Principal Investigator on an R01 grant from NIH to develop brain iron mapping techniques and study the role of iron accumulation in pathogenesis of Parkinson's Disease. The obtained knowledge from this clinical trial would help in future clinical trials aimed to determine if chelation of brain iron in Parkinson’s disease patients produces clinical benefit due to disease modifying effects.
He has been publishing his research findings and has received multiple awards from the American Academy of Neurology.
THANKS TO SPONSORS:
